Solution structure and dynamics of G1TE, a nonphosphorylated cyclic peptide inhibitor for the Grb2 SH2 domain
- PMID: 10600169
- DOI: 10.1006/abbi.1999.1513
Solution structure and dynamics of G1TE, a nonphosphorylated cyclic peptide inhibitor for the Grb2 SH2 domain
Abstract
The solution structure and dynamics of G1TE, a nonphosphorylated cyclic peptide inhibitor for the Grb2 SH2 domain, was determined using two-dimensional NMR and simulated annealing methods. G1TE consists of 10 amino acids and a C-terminal Cys cyclized through its side-chain sulfur atom by a thioether linkage to its N terminus. The results indicate that G1TE assumes a circle-like shape in solution in which all the side chains are protruding outside, and none of the residues are involved in intramolecular hydrogen bonding. The average root-mean-square deviations were found to be 0.41 +/- 0.11 A for the backbone heavy atoms C, Calpha, and N, and 1.03 +/- 0.14 A for all heavy atoms in a family of 10 structures. (15)N relaxation measurements indicate that G1TE has rather restricted dynamics in the fast time scale within its backbone. However, residues Tyr3, Val6, and Gly7 may be involved in a possible conformational exchange. The structural comparison between G1TE in solution and the BCR-Abl phosphopeptide bound to Grb2 SH2 domain revealed that G1TE may form a larger circle-like binding surface than the BCR-Abl phosphopeptide in the bound form. Also, the restricted backbone dynamics of G1TE may result in a reduced loss of entropy and can compensate for the absence of a phosphate group at the Tyr3 position. These structural and dynamic properties of G1TE may provide a molecular basis for understanding its interactions with the Grb2 SH2 domain.
Copyright 1999 Academic Press.
Similar articles
-
Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin.Biochem Biophys Res Commun. 2005 May 20;330(4):1254-61. doi: 10.1016/j.bbrc.2005.03.110. Biochem Biophys Res Commun. 2005. PMID: 15823578
-
Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.J Mol Biol. 2002 Feb 1;315(5):1167-77. doi: 10.1006/jmbi.2001.5299. J Mol Biol. 2002. PMID: 11827484
-
Nuclear magnetic resonance solution structure of the growth factor receptor-bound protein 2 Src homology 2 domain.Biochemistry. 1996 Sep 10;35(36):11852-64. doi: 10.1021/bi952615s. Biochemistry. 1996. PMID: 8794768
-
Grb2 SH2 domain-binding peptide analogs as potential anticancer agents.Biopolymers. 2003;71(2):132-40. doi: 10.1002/bip.10396. Biopolymers. 2003. PMID: 12767115 Review.
-
Structure-based design of compounds inhibiting Grb2-SH2 mediated protein-protein interactions in signal transduction pathways.Curr Pharm Des. 2000 Dec;6(18):1777-96. doi: 10.2174/1381612003398546. Curr Pharm Des. 2000. PMID: 11102562 Review.
Cited by
-
Discovery of thioether-bridged cyclic pentapeptides binding to Grb2-SH2 domain with high affinity.Bioorg Med Chem Lett. 2009 May 15;19(10):2693-8. doi: 10.1016/j.bmcl.2009.03.134. Epub 2009 Mar 29. Bioorg Med Chem Lett. 2009. PMID: 19362470 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous